1.
2.
Eur Respir J
; 59(5)2022 05.
Article
in English
| MEDLINE
| ID: mdl-35236722
3.
Vet Rec
; 186(5): 160-161, 2020 02 08.
Article
in English
| MEDLINE
| ID: mdl-32029672
4.
Vet Rec
; 186(4): 126, 2020 02 01.
Article
in English
| MEDLINE
| ID: mdl-32001587
5.
Vet Rec
; 186(7): 220, 2020 02 22.
Article
in English
| MEDLINE
| ID: mdl-32086418
6.
7.
Pediatr Transplant
; 18(1): E22-4, 2014 Feb.
Article
in English
| MEDLINE
| ID: mdl-24168326
ABSTRACT
AIHA following allogeneic HSCT is appearing more frequently in the literature. It occurs as a result of donor cell-derived antibodies targeting donor red cell antigens. Little guidance exists on the management of such patients, particularly in the pediatric setting. First-line conventional treatment is corticosteroids and/or immunoglobulin therapy with monoclonal antibody therapy reserved for treatment failure. We report our experience of a child refractory to immunoglobulin and steroid therapy who required several infusions of rituximab and immunomodulatory therapy to obtain a clinically significant response.